Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating esophagitis

A composition and technology for esophagitis, applied in the field of western medicine, can solve the problems of interpharyngeal mucosa trauma, ulcers, esophageal stenosis, etc., and achieve non-toxic and side effects, significant curative effect, and quick effect

Inactive Publication Date: 2017-02-22
ZHENGZHOU ZHENGXIAN PHARMA CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The hazards of esophagitis are manifested in the following aspects: On the one hand, esophagitis may cause gastric bleeding. Generally, some patients have hematemesis, some have blood in the stool, and some patients also have iron deficiency anemia. On the other hand, esophagitis may also cause ulcers, which will cause great difficulty for patients to swallow food, and may even penetrate the arteries, causing massive bleeding and life-threatening
If esophagitis is allowed to develop without timely treatment measures, it is likely to cause esophagus stricture, spread to other organs and cause other organ lesions, leading to more serious consequences
[0004] At present, there are many ways to treat esophagitis. Although some problems can be solved, some patients may cause trauma to the interpharyngeal mucosa after treatment, forming scars, resulting in adverse consequences, making the posterior pharyngeal wall atresia, adhesion, and more uncomfortable.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] In an embodiment of the present invention, a pharmaceutical composition for treating esophagitis, the active ingredient is composed of the following components in parts by mass: 12 parts of anisodamine, 0.5 part of tamoxifen, and 59 parts of allicin.

Embodiment 2

[0019] In an embodiment of the present invention, a pharmaceutical composition for treating esophagitis, the active ingredient is composed of the following components in parts by mass: 15 parts of anisodamine, 0.8 part of tamoxifen, and 54 parts of allicin.

Embodiment 3

[0021] In an embodiment of the present invention, a pharmaceutical composition for treating esophagitis, the active ingredient is composed of the following components in parts by mass: 13 parts of anisodamine, 0.6 part of tamoxifen, and 58 parts of allicin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating esophagitis. The medicine composition for treating the esophagitis is prepared from, by mass, 12-15 parts of anisodamine, 0.5-0.8 part of tamoxifen and 54-59 parts of allicin; dosage of administration for an adult is 1.2 mg of active ingredient / kg / day. The medicine composition for treating the esophagitis has the functions of clearing heat, diminishing inflammation, softening hardness to dissipate stagnation, relieving cough and asthma and regulating qi to alleviate pain, and has a remarkable curative effect in treating esophagitis-caused symptoms such as nausea and vomiting, dyspepsia, stomach bloating and hyperacidity. According to clinical experimental verifications, the medicine composition for treating the esophagitis is short in course of treatment, quick in result and free of toxic and side effects, and is worth being applied and popularized.

Description

technical field [0001] The invention relates to the field of western medicine, in particular to a pharmaceutical composition for treating esophagitis. Background technique [0002] Esophagitis generally refers to the inflammation caused by edema and congestion of the esophageal mucosa due to irritation or damage to the superficial or deep layers of the esophageal mucosa. Chemical stimuli include gastric acid, bile, spirits, strong acids, strong alkalis, drugs, etc.; physical stimuli include hot food, drinks, foreign bodies in the esophagus, long-term placement of nasogastric tubes, etc. Esophagitis can also be caused by local damage to the esophagus caused by chemotherapy or radiotherapy, or by mycobacterium tuberculosis, fungal or viral infection caused by the patient's own resistance decline. The most common clinical manifestation is reflux esophagitis caused by acid reflux. [0003] The hazards of esophagitis are manifested in the following aspects: On the one hand, eso...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/46A61P1/04A61P1/08A61P1/14A61K31/138A61K31/255
CPCA61K31/46A61K9/0056A61K31/138A61K31/255
Inventor 不公告发明人
Owner ZHENGZHOU ZHENGXIAN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products